{
    "nctId": "NCT06640881",
    "briefTitle": "Preoperative Partial Breast Reirradiation and Repeat Breast-conserving Surgery in Patients with Recurrent Breast Cancer: the REPEAT Trial",
    "officialTitle": "Preoperative Partial Breast Reirradiation and Repeat Breast-conserving Surgery in Patients with Recurrent Breast Cancer: the REPEAT Trial - a Study Protocol",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Recurrent Breast Carcinoma, Ipsilateral Recurrence",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 25,
    "primaryOutcomeMeasure": "feasibility of single-dose preoperative PB and second BCS for an IRBE after previous BCT based on acute toxicity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female \u2265 50 years with an ipsilateral invasive recurrent breast cancer event after previous breast-conserving surgery and postoperative whole breast irradiation\n* World Health Organization performance status 0-2\n* Tumor size \u2264 2 cm and unifocal on MRI\n* Tumor histology as assessed on biopsy:\n\nBloom-Richardson grade 1 or 2 Non-lobular invasive histological type carcinoma Estrogen receptor positive HER2 receptor negative No lymphovascular invasion\n\n* No extensive DCIS (outside tumor size of 2 cm) on mammography or tumor biopsy, including non-mass enhancement on MRI\n* Clinical node negative on 18-F FDG PET-CT, ultrasound and MRI\n* No distant metastasis\n* No or mild late toxicity (no grade 2 or higher) from previous breast-conserving therapy\n* Adequate understanding of the Dutch language\n\nExclusion Criteria:\n\n* Ipsilateral invasive breast cancer event less than two years after first breast-conserving therapy for breast cancer\n* Other malignancy within 5 years before ipsilateral breast recurrence diagnosis. For carcinoma in situ no specific time span to ipsilateral breast recurrence diagnosis is required for inclusion\n* Known breast cancer mutation gene carrier\n* Collagen synthesis disease (e.g. osteogenesis imperfect, Ehlers-Danlos syndrome, systemic sclerosis)\n* Previous ipsilateral mastectomy\n* Invasive lobular carcinoma, DCIS without invasive cancer\n* MRI absolute contraindications\n* Indication for treatment with neoadjuvant chemotherapy\n* Legal incapacity",
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}